Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies

被引:332
作者
Meune, Christophe [2 ]
Touze, Emmanuel [3 ]
Trinquart, Ludovic [4 ,5 ]
Allanore, Yannick [1 ]
机构
[1] Univ Paris 05, Dept Rheumatol A, Cochin Hosp, Assistance Publ Hop Paris, F-75014 Paris, France
[2] Cochin Hosp, Dept Cardiol, Paris, France
[3] Hop St Anne, Dept Neurol, INSERM, U894, F-75674 Paris, France
[4] Georges Pompidou European Hosp, Clin Res Unit, Paris, France
[5] INSERM, CIE 4, Paris, France
关键词
Rheumatoid arthritis; Cardiovascular mortality; PROSPECTIVE FOLLOW-UP; MYOCARDIAL-INFARCTION; DISEASE ONSET; RISK; POPULATION; SURVIVAL; DEATH; EVENTS; METHOTREXATE; SWEDEN;
D O I
10.1093/rheumatology/kep252
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. RA is known to be associated with a high cardiovascular (CV) risk. Longitudinal data suggest that RA disease course may have become milder over the past decades. Thus, we set out to estimate the magnitude of the overall increase in CV mortality associated with RA and to determine whether it has decreased over the past 50 years. Methods. We performed a systematic review and a meta-analysis of literature in MEDLINE and EMBASE databases from January 1960 to November 2008. All cohort studies reporting CV mortality risk were included. We then calculated pooled standardized mortality ratios (SMRs) of CV mortality, and determined their evolution with time using meta-regression analysis. Results. Seventeen studies were analysed, corresponding to a total of 91916 patients. The overall pooled SMR was 1.6 (95% Cl 1.5, 1.8; I-2=93%; P(het) <0.0001). Mid-cohort year ranged from 1945 to 1995 (<1980, seven studies; 1980-90, five studies; >1990, five studies). Meta-regression analyses revealed neither any trend in SMR over time (P=0.784) nor any relation with disease duration at the time of inclusion (P=0.513). Conclusions. Our results show that RA is associated with a 60% increase in risk of CV death compared with general population. Despite changes in RA course over the past decades, SMR for CV death has not changed. This suggests that targeting a reduction in CV mortality should still be considered as a major issue in RA.
引用
收藏
页码:1309 / 1313
页数:5
相关论文
共 49 条
[2]  
AMETT FC, 1987, ARTHRITIS RHEUM
[3]   Cardiovascular disease in rheumatoid arthritis:: Single-center hospital-based cohort study in France [J].
Assous, Noemie ;
Touze, Emmanuel ;
Meune, Christophe ;
Kahan, Andre ;
Allanore, Yannick .
JOINT BONE SPINE, 2007, 74 (01) :66-72
[4]   Risk of Cardiovascular Mortality in Patients With Rheumatoid Arthritis: A Meta-Analysis of Observational Studies [J].
Avina-Zubieta, J. Antonio ;
Choi, Hyon K. ;
Sadatsafavi, Mohsen ;
Etminan, Mahyar ;
Esdaile, John M. ;
Lacaille, Diane .
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2008, 59 (12) :1690-1697
[5]   Cardiovascular risk in rheumatoid arthritis: effects of anti-TNF drugs [J].
Avouac, J. ;
Allanore, Y. .
EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (07) :1121-1128
[6]  
Bergström U, 1999, SCAND J RHEUMATOL, V28, P160
[7]  
Björnådal L, 2002, J RHEUMATOL, V29, P906
[8]  
Book C, 2005, J RHEUMATOL, V32, P430
[9]  
Breslow NE, 1987, INT AGENCY RES CANC, VII
[10]   The prevalence of rheumatoid arthritis in the general population of Spain [J].
Carmona, L ;
Villaverde, V ;
Hernández-García, C ;
Ballina, J ;
Gabriel, R ;
Laffon, A .
RHEUMATOLOGY, 2002, 41 (01) :88-95